<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BPI</id>
	<title>BPI - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=BPI"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BPI&amp;action=history"/>
	<updated>2026-04-05T21:36:15Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=BPI&amp;diff=6004&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Bactericidal permeability-increasing protein precursor (BPI) (CAP 57)  ==Publications==  {{medline-entry |title=High TARC plasma levels confer protection to long...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=BPI&amp;diff=6004&amp;oldid=prev"/>
		<updated>2021-05-12T15:05:19Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Bactericidal permeability-increasing protein precursor (BPI) (CAP 57)  ==Publications==  {{medline-entry |title=High TARC plasma levels confer protection to long...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Bactericidal permeability-increasing protein precursor (BPI) (CAP 57)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=High TARC plasma levels confer protection to long living individuals by inducing M2 profile.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33002742&lt;br /&gt;
|abstract=A way to delay aging and the related low-grade chronic inflammatory state is to study the model of positive physiology such as the Long-Living Individuals (LLIs). Our recent studies have shown higher levels of the host defense [[BPI]] Fold-Containing Family B Member 4 ([[BPI]]FB4) protein in the LLIs&amp;#039; blood. Notably, [[BPI]]FB4 has been shown to influence monocytes typesetting and M2 anti-inflammatory phenotype (CD206 CD163  ) macrophages skewing. According to the role of a complex cytokine milieu in guiding the macrophage polarization, here we found that circulating concentrations of thymus and activation regulated chemokine (TARC)/CCL17 and small-inducible cytokine B10 (IP-10)/CXCL10) cytokines, were additionally associated with the LLIs&amp;#039; state. In a differentiation process in vitro, the addition of LLIs&amp;#039; plasma to the cell culture medium, enhanced the ability of monocytes, either from LLIs or controls, to acquire a M2 phenotype. Interestingly, a neutralizing antibody against TARC blunted the M2 skewing effect of the LLIs&amp;#039; plasma. Collectively, these data indicate that exceptional longevity may associate with a peculiar anti-inflammatory myeloid profile responsible for improved reparative processes and reduced inflammatory status mediated in part by TARC and M2 generation.&lt;br /&gt;
&lt;br /&gt;
|keywords=* FACS&lt;br /&gt;
* Longevity&lt;br /&gt;
* M2 macrophages&lt;br /&gt;
* Plasma profile&lt;br /&gt;
* TARC&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1016/j.cyto.2020.155305&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Circulating [[BPI]]FB4 Levels Associate With and Influence the Abundance of Reparative Monocytes and Macrophages in Long Living Individuals.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32547549&lt;br /&gt;
|abstract=Long-Living Individuals (LLIs) delay aging and are less prone to chronic inflammatory reactions. Whether a distinct monocytes and macrophages repertoire is involved in such a characteristic remains unknown. Previous studies from our group have shown high levels of the host defense [[BPI]] Fold Containing Family B Member 4 ([[BPI]]FB4) protein in the peripheral blood of LLIs. Moreover, a polymorphic variant of the [i][[BPI]]FB4[/i] gene associated with exceptional longevity ([i]LAV-[[BPI]]FB4[/i]) confers protection from cardiovascular diseases underpinned by low-grade chronic inflammation, such as atherosclerosis. We hypothesize that [[BPI]]FB4 may influence monocytes pool and macrophages skewing, shifting the balance toward an anti-inflammatory phenotype. We profiled circulating monocytes in 52 LLIs (median-age 97) and 52 healthy volunteers (median-age 55) using flow cytometry. If the frequency of total monocyte did not change, the intermediate CD14  CD16  monocytes counts were lower in LLIs compared to control adults. Conversely, non-classical CD14 CD16   monocyte counts, which are M2 macrophage precursors with an immunomodulatory function, were found significantly associated with the LLIs&amp;#039; state. In a differentiation assay, supplementation of the LLIs&amp;#039; plasma enhanced the capacity of monocytes, either from LLIs or controls, to acquire a paracrine M2 phenotype. A neutralizing antibody against the phosphorylation site (ser 75) of [[BPI]]FB4 blunted the M2 skewing effect of the LLIs&amp;#039; plasma. These data indicate that LLIs carry a peculiar anti-inflammatory myeloid profile, which is associated with and possibly sustained by high circulating levels of [[BPI]]FB4. Supplementation of recombinant [[BPI]]FB4 may represent a novel means to attenuate inflammation-related conditions typical of unhealthy aging.&lt;br /&gt;
&lt;br /&gt;
|keywords=* FACS&lt;br /&gt;
* M2 macrophages&lt;br /&gt;
* immunity&lt;br /&gt;
* longevity&lt;br /&gt;
* patrolling-monocytes&lt;br /&gt;
* plasma&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272600&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=The effect of postural deformities on back function and pain in patients with Parkinson&amp;#039;s disease.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31177242&lt;br /&gt;
|abstract=Postural deformities, such as Pisa syndrome (PS), and camptocormia and antecollis (C&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>